Recent advances and new strategies on leishmaniasis treatment

BM Roatt, JM de Oliveira Cardoso… - Applied Microbiology …, 2020 - Springer
Leishmaniasis is one of the most important tropical neglected diseases according to the
World Health Organization. Even after more than a century, we still have few drugs for the …

Advancement in leishmaniasis diagnosis and therapeutics: An update

D Kumari, S Perveen, R Sharma, K Singh - European Journal of …, 2021 - Elsevier
Leishmaniasis is regarded as a neglected tropical disease by World Health Organization
(WHO) and is ranked next to malaria as the deadliest protozoan disease. The primary …

Current leishmaniasis drug discovery

AC Pinheiro, MVN de Souza - RSC Medicinal Chemistry, 2022 - pubs.rsc.org
Leishmaniasis is a complex protozoan infectious disease and, associated with malnutrition,
poor health services and unavailability of prophylactic control measures, neglected …

Use of artificial intelligence and machine learning for discovery of drugs for neglected tropical diseases

DA Winkler - Frontiers in Chemistry, 2021 - frontiersin.org
Neglected tropical diseases continue to create high levels of morbidity and mortality in a
sizeable fraction of the world's population, despite ongoing research into new treatments …

Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo …

ALS Santos, LA Braga-Silva, DS Gonçalves, LS Ramos… - Journal of Fungi, 2021 - mdpi.com
The repurposing strategy was applied herein to evaluate the effects of lopinavir, an aspartic
protease inhibitor currently used in the treatment of HIV-infected individuals, on the globally …

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates

S Jain, U Sahu, A Kumar, P Khare - Pharmaceutics, 2022 - mdpi.com
Leishmaniasis is a tropical disease caused by a protozoan parasite Leishmania that is
transmitted via infected female sandflies. At present, leishmaniasis treatment mainly counts …

Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling

PO Sakyi, SK Kwofie, JK Tuekpe, TM Gwira, E Broni… - Pharmaceuticals, 2023 - mdpi.com
The recent outlook of leishmaniasis as a global public health concern coupled with the
reportage of resistance and lack of efficacy of most antileishmanial drugs calls for a …

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

H Berhe, M Kumar Cinthakunta Sridhar, M Zerihun… - Pharmaceutics, 2024 - mdpi.com
Chagas disease and leishmaniasis are both neglected tropical diseases that affect millions
of people around the world. Leishmaniasis is currently the second most widespread vector …

Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species

R Ochoa, A Ortega-Pajares, FA Castello, F Serral… - Biomolecules, 2021 - mdpi.com
Leishmaniasis is a public health disease that requires the development of more effective
treatments and the identification of novel molecular targets. Since blocking the PI3K/AKT …

Physical-chemical repurposing of drugs. History of its formation in Russia

AL Urakov, PD Shabanov - Reviews on Clinical …, 2023 - journals.eco-vector.com
It is reported that the traditional scheme of finding and developing a new drug and
conducting the whole complex of preclinical studies requires several thousand chemical …